Semiconductor technologies are playing an increasingly important role in these advances, and enabling significant system level performance improvements which make a difference in human health. Advances in MEMS, nanofluidics, and low-power electronics are enabling biomedical innovation in healthcare and life sciences.

With ISO 13485 certification, SkyWater has a successful track record developing, qualifying, and scaling custom components for domestic volume manufacturing.​

Healthcare

Design Trends​

  • Broad system repartitioning, functional integration in medical devices
  • Genetics advances driving sensor and detection innovation in medical devices for chronic disease treatment
  • MEMS and CMOS + X (application-specific special materials such as Platinum and sensor functions) implemented in roadmap designs

Market Dynamics​

  • Changes in regulatory environment pushing medical-grade performance into consumer health
  • Foundries and IC device manufacturers exiting biomedical market or reducing support for needed technologies
  • Broad re-shoring of key system technologies and manufacturing over geopolitical uncertainty, IP concerns

Life Sciences

Design Trends​

  • Miniaturization and integration of semiconductor technology in consumables for Lab-on-Chip and microfluidic applications
  • High specificity and sensitivity enabled by custom semiconductor technology
  • AI and machine learning accelerating drug discovery

Market Dynamics​

  • Growing demand for personalized medicine on a wide range of diseases for an aging population​
  • Post-COVID investment environment necessitates fast time to market​, scale from start
  • Collaboration and partnerships which enable disruptive innovation that can scale quickly
  • Global health initiatives drive need for technology and business model innovation

Unique structures for rapid diagnostics and genetic sequencing

Semiconductor technology is not only for active devices. In a rapidly growing scope and scale of applications, healthcare innovators are leveraging the combination of small feature size, large production volume, and high quality to create differentiated structures for diagnostic and sequencing applications.

Rad-Hard ASICs for imaging and implantable medical device applications

When up-time and reliability matter most, radiation hardened semiconductors ensure performance and reliability. Offered with different levels of radiation tolerance up to Strategic Rad-Hard, SkyWater has a scalable 90nm CMOS foundry process technology for vital components.

Sensors for patient monitoring

Emerging new sensor types are bringing improved performance and value to an expanding number of healthcare applications. Whether measured by photonic, chemical, or biopotential means, many have been enabled by unique new process technologies developed specifically for the application, not from standard building blocks. SkyWater has a proven track record of innovation and accelerating time to market on custom process flows.

CMOS + X

CMOS + X is an emerging design trend in which the combination of a standard CMOS process plus the addition of custom technologies/materials enhance system level performance and capabilities. Examples include, but are not limited to, Platinum, or Pt, and other noble materials. SkyWater is experienced in modifying standard CMOS processes to add capabilities which enable differentiated performance.

Carbon Nanotubes, or CNTs, for biosensors and drug delivery

Carbon nanotubes have a set of electrical, optical, chemical and other properties that make them attractive for a range of treatment, detection and monitoring applications. Having demonstrated carbon nanotube integration with its 130nm CMOS process technology, SkyWater is a pioneer in this emerging field.

Connect with us on LinkedIn

Let’s make your next project a reality.

Get Started